Print Page  |  Close Window

SEC
10-Q
BIOTELEMETRY, INC. filed this Form 10-Q on 10/31/2018
Entire Document
 << Previous Page | Next Page >>


BIOTELEMETRY, INC.
CONSOLIDATED STATEMENT OF EQUITY
(Unaudited)

 
BioTelemetry, Inc. Equity
 
 
 
 
 
Common Stock
 
Paid-in Capital
 
Accumulated
Other
Comprehensive
Loss
 
Accumulated Deficit
 
Noncontrolling Interest
 
Total Equity
(in thousands, except shares)
Shares
 
Amount
 
 
 
 
 
Balance at December 31, 2017
32,460,668

 
$
32

 
$
409,517

 
$
(114
)
 
$
(158,678
)
 
$
(1,054
)
 
$
249,703

Share issuances related to stock compensation plans
777,781

 
1

 
11,136

 

 

 

 
11,137

Stock-based compensation

 

 
6,278

 

 

 

 
6,278

Shares withheld to cover taxes on vesting of share based awards
(85,177
)
 

 
(2,890
)
 

 

 

 
(2,890
)
Acquisition of noncontrolling interests
58,786

 

 
(2,000
)
 

 

 
2,000

 

Currency translation adjustment

 

 

 
(194
)
 

 

 
(194
)
Net income/(loss)

 

 

 

 
32,427

 
(946
)
 
31,481

Balance at September 30, 2018
33,212,058

 
$
33

 
$
422,041

 
$
(308
)
 
$
(126,251
)
 
$

 
$
295,515




See accompanying Notes to Consolidated Financial Statements.


8

 << Previous Page | Next Page >>